Perrigo | Ativo Circulante



Current Assets Alterar Data
AbbVie USD 25.58B 2.2B 2024-12
Abbott USD 23.66B 146M 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Dr.Reddys Laboratories INR 253.02B 4.82B 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
J&J USD 55.89B 2.64B 2024-12
Merck USD 38.78B 1.58B 2024-12
Nestle CHF 35.19B 1.26B 2024-12
Pacira USD 745.13M 55.16M 2024-12
Perrigo USD 2.48B 1.23B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Prestige Brands USD 377.16M 3.54M 2024-12
Reckitt Benckiser GBP 4.6B 287M 2024-12
Sanofi 30.08B 589M 2024-06
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Teva Pharmaceutical Industries USD 12.55B 238M 2024-12
Xeris Pharmaceuticals USD 167.66M 4.86M 2024-12
Zoetis USD 5.99B 296M 2024-12



Perrigo Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.